Stanek, Timothy J.
Johns Hopkins University · Thomas Jefferson University · Tampere University Hospital · Sidney Kimmel Comprehensive Cancer Center · University of Tampere
3 papers on CoChatORCID 0000-0001-9192-4978
Most cited papers
- Verified
USP22 regulates oncogenic signaling pathways to drive lethal cancer progression
Schrecengost, R. S., Dean, J. L., Goodwin, J. F., Schiewer, M. J., Urban, M. W., Stanek, T. J., Sussman, R. T., Hicks, J. L., Birbe, R. C., Draganova-Tacheva, R. A., et al. (2014) · Cancer Research
Ubiquitin and proteasome pathwaysProstate Cancer Treatment and Research
Cited by 126
- Verified
ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice
Casimiro, M. C., Crosariol, M., Loro, E., Ertel, A., Yu, Z., Dampier, W., Saria, E. A., Papanikolaou, A., Stanek, T. J., Li, Z., et al. (2012) · Journal of Clinical Investigation
Microtubule and mitosis dynamicsCancer-related Molecular Pathways
Cited by 115
- Verified
The epigenetic modifier ubiquitin-specific protease 22 (USP22) regulates embryonic stem cell differentiation via transcriptional repression of sex-determining region Y-box 2 (SOX2)
Sussman, R. T., Stanek, T. J., Esteso, P., Gearhart, J. D., Knudsen, K. E., & McMahon, S. B. (2013) · Journal of Biological Chemistry
Pluripotent Stem Cells ResearchEpigenetics and DNA Methylation
Cited by 91
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free